Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore
- Corporate and Finance
- COVID-19
Nov 24, 2021
Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference

Nov 23, 2021
Novavax Statement on Publication of Positive Results from First Study of Co-administered COVID-19 and Influenza Vaccines
- Statement
- COVID-19
Nov 18, 2021
Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization
- COVID-19
Nov 17, 2021
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
- Corporate and Finance
- COVID-19
Nov 17, 2021
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

Nov 15, 2021
Novavax Statement on UK and Mexico Phase 3 Clinical Trial Participants Considered Fully Vaccinated in the US
- Statement
- COVID-19
Nov 10, 2021
Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights
- Corporate and Finance
Nov 4, 2021
Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization
- Corporate and Finance
- COVID-19
Nov 4, 2021
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
- COVID-19
Nov 3, 2021

Show per page